Artal Group’s Astria Therapeutics ATXS Stock Holding History

Artal Group’s Portfolio ATXS Stock Details ATXS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell
2024 Q1	$12.4M	Buy
2022 Q4	–	Sell
2022 Q3	$301K	Hold
2022 Q2	$100K	Hold
2022 Q1	$224K	Hold
2021 Q4	$180K	Hold
2021 Q3	$295K	Buy